Terms: = Breast cancer AND ARHGEF12, Q9NZN5, 23365, ENSG00000196914, KIAA0382, LARG, DKFZp686O2372, PRO2792
17 results:
1. Nitric oxide nano-reactor DNMF/PLGA enables tumor vascular microenvironment and chemo-hyperthermia synergetic therapy.
Wang R; Cheng L; He L; Du C; Wang H; Peng B; Yu X; Liu W; Luo W; Ran H; Yang L
J Nanobiotechnology; 2024 Mar; 22(1):110. PubMed ID: 38481281
[TBL] [Abstract] [Full Text] [Related]
2. Glutathione Depletion-Induced ROS/NO Generation for Cascade breast cancer Therapy and Enhanced Anti-Tumor Immune Response.
Wang J; Sang Y; Chen W; Cheng L; Du W; Zhang H; Zheng B; Song L; Hu Y; Ma X
Int J Nanomedicine; 2024; 19():2301-2315. PubMed ID: 38469056
[TBL] [Abstract] [Full Text] [Related]
3. Antiproliferative and Antimigratory Activity of Poly-gallic Acid in cancer Cell Lines.
Hernandez-Valencia CG; Rodriguez-Martinez G; Carriles-Perez AM; Gonzalez-Perez D; Ortega-Sanchez C; Andonegui-Elguera MA; Zamudio-Cuevas Y; Fernandez-Torres J; Hernandez-Valdepena MA; Gimeno M; Sanchez-Sanchez R
Anticancer Res; 2024 Mar; 44(3):1201-1208. PubMed ID: 38423672
[TBL] [Abstract] [Full Text] [Related]
4. Nanodrugs mediate TAMs-related arginine metabolism interference to boost photodynamic immunotherapy.
Chen Y; Shu X; Guo JY; Xiang Y; Liang SY; Lai JM; Zhou JY; Liu LH; Wang P
J Control Release; 2024 Mar; 367():248-264. PubMed ID: 38272398
[TBL] [Abstract] [Full Text] [Related]
5. Mitochondria-Targeted Mesoporous Titanium Dioxide Nanoplatform for Synergistic Nitric Oxide Gas-Sonodynamic Therapy of breast cancer.
Zuo S; Zhang Y; Wang Z; Wang J
Int J Nanomedicine; 2022; 17():989-1002. PubMed ID: 35280333
[TBL] [Abstract] [Full Text] [Related]
6. Endogenous NO-releasing Carbon Nanodots for Tumor-specific Gas Therapy.
Liu X; Liu Y; Thakor AS; Kevadiya BD; Cheng J; Chen M; Li Y; Xu Q; Wu Q; Wu Y; Zhang G
Acta Biomater; 2021 Dec; 136():485-494. PubMed ID: 34601108
[TBL] [Abstract] [Full Text] [Related]
7. Tumor Microenvironment-Activatable Cyclic Cascade Reaction to Reinforce Multimodal Combination Therapy by Destroying the Extracellular Matrix.
Su Y; Zhang X; Lei L; Liu B; Wu S; Shen J
ACS Appl Mater Interfaces; 2021 Mar; 13(11):12960-12971. PubMed ID: 33720684
[TBL] [Abstract] [Full Text] [Related]
8. The RGS-RhoGEFs control the amplitude of YAP1 activation by serum.
Lane BS; Heller B; Hollenberg MD; Wells CD
Sci Rep; 2021 Jan; 11(1):2348. PubMed ID: 33504879
[TBL] [Abstract] [Full Text] [Related]
9. Increased photodynamic therapy sensitization in tumors using a nitric oxide-based nanoplatform with ATP-production blocking capability.
Xiang Q; Qiao B; Luo Y; Cao J; Fan K; Hu X; Hao L; Cao Y; Zhang Q; Wang Z
Theranostics; 2021; 11(4):1953-1969. PubMed ID: 33408791
[TBL] [Abstract] [Full Text] [Related]
10. Nitric Oxide Stimulated Programmable Drug Release of Nanosystem for Multidrug Resistance cancer Therapy.
Wang L; Chang Y; Feng Y; Li X; Cheng Y; Jian H; Ma X; Zheng R; Wu X; Xu K; Zhang H
Nano Lett; 2019 Oct; 19(10):6800-6811. PubMed ID: 31466437
[TBL] [Abstract] [Full Text] [Related]
11. Sema4C/PlexinB2 signaling controls breast cancer cell growth, hormonal dependence and tumorigenic potential.
Gurrapu S; Pupo E; Franzolin G; Lanzetti L; Tamagnone L
Cell Death Differ; 2018 Jul; 25(7):1259-1275. PubMed ID: 29555978
[TBL] [Abstract] [Full Text] [Related]
12. l-arginine and docetaxel synergistically enhance anti-tumor immunity by modifying the immune status of tumor-bearing mice.
Cao Y; Wang Q; Du Y; Liu F; Zhang Y; Feng Y; Jin F
Int Immunopharmacol; 2016 Jun; 35():7-14. PubMed ID: 27003114
[TBL] [Abstract] [Full Text] [Related]
13. L-Canavanine Potentiates Cytotoxicity of Chemotherapeutic Drugs in Human breast cancer Cells.
Nurcahyanti AD; Wink M
Anticancer Agents Med Chem; 2017; 17(2):206-211. PubMed ID: 26902604
[TBL] [Abstract] [Full Text] [Related]
14. PDZ-RhoGEF is essential for CXCR4-driven breast tumor cell motility through spatial regulation of RhoA.
Struckhoff AP; Rana MK; Kher SS; Burow ME; Hagan JL; Del Valle L; Worthylake RA
J Cell Sci; 2013 Oct; 126(Pt 19):4514-26. PubMed ID: 23868972
[TBL] [Abstract] [Full Text] [Related]
15. Small-molecule inhibitors targeting G-protein-coupled Rho guanine nucleotide exchange factors.
Shang X; Marchioni F; Evelyn CR; Sipes N; Zhou X; Seibel W; Wortman M; Zheng Y
Proc Natl Acad Sci U S A; 2013 Feb; 110(8):3155-60. PubMed ID: 23382194
[TBL] [Abstract] [Full Text] [Related]
16. larg at chromosome 11q23 has functional characteristics of a tumor suppressor in human breast and colorectal cancer.
Ong DC; Ho YM; Rudduck C; Chin K; Kuo WL; Lie DK; Chua CL; Tan PH; Eu KW; Seow-Choen F; Wong CY; Hong GS; Gray JW; Lee AS
Oncogene; 2009 Nov; 28(47):4189-200. PubMed ID: 19734946
[TBL] [Abstract] [Full Text] [Related]
17. Prolactin and estrogen up-regulate carboxypeptidase-d to promote nitric oxide production and survival of mcf-7 breast cancer cells.
Abdelmagid SA; Too CK
Endocrinology; 2008 Oct; 149(10):4821-8. PubMed ID: 18535109
[TBL] [Abstract] [Full Text] [Related]
